Nobilis Therapeutics and Submersible Systems Partner to Create a Portable Inhalation Device for Administration of NBTX-001, a Medical Gas-based Drug Candidate PORTLAND, OR and HUNTINGTON BEACH, CA--(Marketwired - May 10, 2017) - Nobilis Therapeutics, Inc., a biotechnology company developing inhalation-based therapeutics to treat psychiatric and...

Nobilis Therapeutics Recruits Internationally Renowned Xenon Expert to Scientific Advisory Board SAN DIEGO, CA--(Marketwired - April 11, 2016) - Nobilis Therapeutics, today announced that Dr. Daqing Ma, MD, PhD, FRCA, a Macintosh Professor of Anesthesia and the Head of Anesthesia Research...

Nobilis Therapeutics Signs Exclusive License Agreement with Harvard University for PTSD Treatment SAN DIEGO, CA--(Marketwired - March 28, 2016) - Nobilis Therapeutics, Inc. announced today entry into an exclusive agreement with Harvard University's Partners Healthcare to license intellectual...

Nobilis Therapeutics Files Patent on Noble Gas Treatment for Alzheimer's Disease SAN DIEGO, CA--(Marketwired - Jan 19, 2016) - Nobilis Therapeutics, a biotechnology company dedicated to clinical development of Noble Gas-based medical interventions, announced today filing of a...